Skip to main content
. 2016 Dec 27;8(4):6663–6680. doi: 10.18632/oncotarget.14255

Figure 4. MiR-23b is decreased in TSCC specimens.

Figure 4

A. Relative levels of miR-23b in 63 TSCC specimens and adjacent nonmalignant tissues. Data were presented as relative fold change (ΔΔCT values). B. MiR-23b expression levels from tumors were normalized to their corresponding control and the percentage of cases for the indicated expression in the tumor represented as a pie chart. C. Relative miR-23b levels for 63 specimens of TSCC and its counterparts. Data were presented as relative mRNA fold change. **P < 0.01. The correlation between IL-17A and miR-23b expression in 63 pairs of TSCC samples D. in 30 paired specimens of TSCC patients with cervical metastasis E. and in 33 paired specimens of TSCC patients with advanced stages F. Values were presented with linear regression line and analyzed with Pearson's correlation method.